CD14 Plays a Protective Role in Experimental Inflammatory Bowel Disease by Enhancing Intestinal Barrier Function

American Journal of Pathology

Volumn 187, Issue 5, 2017, Pages 1106-1120

  Buchheister, Stephanie ^a   Buettner, Manuela ^a   Basic, Marijana ^a   Noack, Andreas ^b   Breves, Gerhard ^b   Buchen, Barbara ^c   Keubler, Lydia M ^a   Becker, Christoph ^c   Bleich, André ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CLAUDIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYOSIN LIGHT CHAIN KINASE; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR; INTERLEUKIN 10; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSLOCATION; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; INFLAMMATORY BOWEL DISEASE; INTESTINE FUNCTION; INTESTINE PROTECTION; LAMINA PROPRIA; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; UPREGULATION; WESTERN BLOTTING; ACUTE DISEASE; ANIMAL; C57BL MOUSE; COLITIS; COLON; DEFICIENCY; DISEASE MODEL; INTESTINE MUCOSA; MALE; METABOLISM; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD14; COLITIS; COLON; DISEASE MODELS, ANIMAL; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTESTINAL MUCOSA; MALE; MICE, INBRED C57BL; MYOSIN-LIGHT-CHAIN KINASE; NF-KAPPA B; PERMEABILITY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 85017436669     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2017.01.012     Document Type: Article

References (60)

1. 1 Keubler, L.M., Buettner, M., Hager, C., Bleich, A., A multihit model: colitis lessons from the interleukin-10-deficient mouse. Inflamm Bowel Dis 21 (2015), 1967–1975.
2. 2 Ek, W.E., D'Amato, M., Halfvarson, J., The history of genetics in inflammatory bowel disease. Ann Gastroenterol 27 (2014), 294–303.
3. 3 Anderson, C.A., Massey, D.C., Barrett, J.C., Prescott, N.J., Tremelling, M., Fisher, S.A., Gwilliam, R., Jacob, J., Nimmo, E.R., Drummond, H., Lees, C.W., Onnie, C.M., Hanson, C., Blaszczyk, K., Ravindrarajah, R., Hunt, S., Varma, D., Hammond, N., Lewis, G., Attlesey, H., Watkins, N., Ouwehand, W., Strachan, D., McArdle, W., Lewis, C.M.Wellcome Trust Case Control Consortium, Lobo, A., Sanderson, J., Jewell, D.P., Deloukas, P., Mansfield, J.C., Mathew, C.G., Satsangi, J., Parkes, M., Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 136 (2009), 523–529.e3.
4. 4 Fisher, S.A., Tremelling, M., Anderson, C.A., Gwilliam, R., Bumpstead, S., Prescott, N.J., Nimmo, E.R., Massey, D., Berzuini, C., Johnson, C., Barrett, J.C., Cummings, F.R., Drummond, H., Lees, C.W., Onnie, C.M., Hanson, C.E., Blaszczyk, K., Inouye, M., Ewels, P., Ravindrarajah, R., Keniry, A., Hunt, S., Carter, M., Watkins, N., Ouwehand, W., Lewis, C.M., Cardon, L.Wellcome Trust Case Control Consortium, Lobo, A., Forbes, A., Sanderson, J., Jewell, D.P., Mansfield, J.C., Deloukas, P., Mathew, C.G., Parkes, M., Satsangi, J., Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 40 (2008), 710–712.
5. 5 Mähler, M., Most, C., Schmidtke, S., Sundberg, J.P., Li, R., Hedrich, H.J., Churchill, G.A., Genetics of colitis susceptibility in IL-10-deficient mice: backcross versus F2 results contrasted by principal component analysis. Genomics 80 (2002), 274–282.
6. 6 Farmer, M.A., Sundberg, J.P., Bristol, I.J., Churchill, G.A., Li, R., Elson, C.O., Leiter, E.H., A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sci U S A 98 (2001), 13820–13825.
7. 7 de Buhr, M.F., Mähler, M., Geffers, R., Hansen, W., Westendorf, A.M., Lauber, J., Buer, J., Schlegelberger, B., Hedrich, H.J., Bleich, A., Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol Genomics 25 (2006), 426–434.
8. 8 Kamada, N., Hisamatsu, T., Okamoto, S., Chinen, H., Kobayashi, T., Sato, T., Sakuraba, A., Kitazume, M.T., Sugita, A., Koganei, K., Akagawa, K.S., Hibi, T., Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest 118 (2008), 2269–2280.
9. 9 de Buhr, M.F., Hedrich, H.J., Westendorf, A.M., Obermeier, F., Hofmann, C., Zschemisch, N.H., Buer, J., Bumann, D., Goyert, S.M., Bleich, A., Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice. Inflam Bowel Dis 15 (2009), 1824–1836.
10. 10 Beitnes, A.C., Raki, M., Brottveit, M., Lundin, K.E., Jahnsen, F.L., Sollid, L.M., Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge. PLoS One, 7, 2012, e33556.
11. 11 Antal-Szalmas, P., Strijp, J.A., Weersink, A.J., Verhoef, J., Van Kessel, K.P., Quantitation of surface CD14 on human monocytes and neutrophils. J Leukoc Biol 61 (1997), 721–728.
12. 12 Zanoni, I., Granucci, F., Role of CD14 in host protection against infections and in metabolism regulation. Front Cell Infect Microbiol, 3, 2013, 32.
13. 13 Kitchens, R.L., Thompson, P.A., Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 11 (2005), 225–229.
14. 14 Thiesen, S., Janciauskiene, S., Uronen-Hansson, H., Agace, W., Hogerkorp, C.M., Spee, P., Hakansson, K., Grip, O., CD14(hi)HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease. J Leukoc Biol 95 (2014), 531–541.
15. 15 Shen, L., Weber, C.R., Raleigh, D.R., Yu, D., Turner, J.R., Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 73 (2011), 283–309.
16. 16 Turner, J.R., Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9 (2009), 799–809.
17. 17 Barreau, F., Hugot, J.P., Intestinal barrier dysfunction triggered by invasive bacteria. Curr Opin Microbiol 17 (2014), 91–98.
18. 18 Akira, S., Hoshino, K., Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling. J Infect Dis 187:Suppl 2 (2003), S356–S363.
19. 19 Steinbrecher, K.A., Harmel-Laws, E., Sitcheran, R., Baldwin, A.S., Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation. J Immunol 180 (2008), 2588–2599.
20. 20 Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., Gumucio, D., Neurath, M.F., Pasparakis, M., Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446 (2007), 557–561.
21. 21 Tamura, Y., Higuchi, Y., Kataoka, M., Akizuki, S., Matsuura, K., Yamamoto, S., CD14 transgenic mice expressing membrane and soluble forms: comparisons of levels of cytokines and lethalities in response to lipopolysaccharide between transgenic and non-transgenic mice. Int Immunol 11 (1999), 333–339.
22. 22 Hoesel, B., Schmid, J.A., The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer, 12, 2013, 86.
23. 23 Janus, L.M., Smoczek, A., Jorns, A., Hedrich, H.J., Bleich, A., Presence of Minute virus of mice in immunocompetent mice despite the onset of host immunity. Vet Microbiol 146 (2010), 51–58.
24. 24 Bleich, A., Mähler, M., Most, C., Leiter, E.H., Liebler-Tenorio, E., Elson, C.O., Hedrich, H.J., Schlegelberger, B., Sundberg, J.P., Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome 15 (2004), 865–871.
25. 25 Hager, C., Keubler, L.M., Biernot, S., Dietrich, J., Buchheister, S., Buettner, M., Bleich, A., Time to integrate to Nest Test evaluation in a mouse DSS-colitis model. PLoS One, 10, 2015, e0143824.
26. 26 Bleich, E.M., Leonhard-Marek, S., Beyerbach, M., Breves, G., Characterisation of chloride currents across the proximal colon in CftrTgH(neoim)1Hgu congenic mice. J Comp Physiol B 177 (2007), 61–73.
27. 27 Toth, B., Leonhard-Marek, S., Hedrich, H.J., Breves, G., Characterisation of electrogenic nutrient absorption in the Cftr TgH(neoim)Hgu mouse model. J Comp Physiol B 178 (2008), 705–712.
28. 28 Schroeder, B., Duncker, S., Barth, S., Bauerfeind, R., Gruber, A.D., Deppenmeier, S., Breves, G., Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. Dig Dis Sci 51 (2006), 724–731.
29. 29 Schultz, S.G., Zalusky, R., Ion transport in isolated rabbit ileum, I: short-circuit current and Na fluxes. J Gen Physiol 47 (1964), 567–584.
30. 30 Cario, E., Rosenberg, I.M., Brandwein, S.L., Beck, P.L., Reinecker, H.C., Podolsky, D.K., Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164 (2000), 966–972.
31. 31 Guo, S., Al-Sadi, R., Said, H.M., Ma, T.Y., Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol 182 (2013), 375–387.
32. 32 Al-Sadi, R., Boivin, M., Ma, T., Mechanism of cytokine modulation of epithelial tight junction barrier. Front Biosci (Landmark Ed) 14 (2009), 2765–2778.
33. 33 Wang, F., Graham, W.V., Wang, Y., Witkowski, E.D., Schwarz, B.T., Turner, J.R., Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166 (2005), 409–419.
34. 34 Ye, D., Guo, S., Al-Sadi, R., Ma, T.Y., MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology 141 (2011), 1323–1333.
35. 35 Su, L., Nalle, S.C., Shen, L., Turner, E.S., Singh, G., Breskin, L.A., Khramtsova, E.A., Khramtsova, G., Tsai, P.Y., Fu, Y.X., Abraham, C., Turner, J.R., TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 145 (2013), 407–415.
36. 36 Ortega-Cava, C.F., Ishihara, S., Rumi, M.A., Kawashima, K., Ishimura, N., Kazumori, H., Udagawa, J., Kadowaki, Y., Kinoshita, Y., Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol 170 (2003), 3977–3985.
37. 37 Sekirov, I., Russell, S.L., Antunes, L.C., Finlay, B.B., Gut microbiota in health and disease. Physiol Rev 90 (2010), 859–904.
38. 38 Artis, D., Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8 (2008), 411–420.
39. 39 Morrissey, J., Guo, G., McCracken, R., Tolley, T., Klahr, S., Induction of CD14 in tubular epithelial cells during kidney disease. J Am Soc Nephrol 11 (2000), 1681–1690.
40. 40 Frey, E.A., Miller, D.S., Jahr, T.G., Sundan, A., Bazil, V., Espevik, T., Finlay, B.B., Wright, S.D., Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 176 (1992), 1665–1671.
41. 41 Hornef, M.W., Frisan, T., Vandewalle, A., Normark, S., Richter-Dahlfors, A., Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 195 (2002), 559–570.
42. 42 Clarke, T.B., Francella, N., Huegel, A., Weiser, J.N., Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe 9 (2011), 404–414.
43. 43 Dentener, M.A., Bazil, V., Von Asmuth, E.J., Ceska, M., Buurman, W.A., Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 150 (1993), 2885–2891.
44. 44 Perera, P.Y., Vogel, S.N., Detore, G.R., Haziot, A., Goyert, S.M., CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J Immunol 158 (1997), 4422–4429.
45. 45 Feghali, K., Tanabe, S., Grenier, D., Soluble CD14 induces cytokine release by human oral epithelial cells. J Periodontal Res 46 (2011), 147–152.
46. 46 Lloyd-Jones, K.L., Kelly, M.M., Kubes, P., Varying importance of soluble and membrane CD14 in endothelial detection of lipopolysaccharide. J Immunol 181 (2008), 1446–1453.
47. 47 Moore, K.J., Andersson, L.P., Ingalls, R.R., Monks, B.G., Li, R., Arnaout, M.A., Golenbock, D.T., Freeman, M.W., Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol 165 (2000), 4272–4280.
48. 48 Fukata, M., Michelsen, K.S., Eri, R., Thomas, L.S., Hu, B., Lukasek, K., Nast, C.C., Lechago, J., Xu, R., Naiki, Y., Soliman, A., Arditi, M., Abreu, M.T., Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288 (2005), G1055–G1065.
49. 49 Slack, E., Hapfelmeier, S., Stecher, B., Velykoredko, Y., Stoel, M., Lawson, M.A., Geuking, M.B., Beutler, B., Tedder, T.F., Hardt, W.D., Bercik, P., Verdu, E.F., McCoy, K.D., Macpherson, A.J., Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325 (2009), 617–620.
50. 50 Ukena, S.N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., Suerbaum, S., Buer, J., Gunzer, F., Westendorf, A.M., Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One, 2, 2007, e1308.
51. 51 Bleich, A., Sundberg, J.P., Smoczek, A., von Wasielewski, R., de Buhr, M.F., Janus, L.M., Julga, G., Ukena, S.N., Hedrich, H.J., Gunzer, F., Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background. Int J Exp Pathol 89 (2008), 45–54.
52. 52 Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R., Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004), 229–241.
53. 53 Araki, A., Kanai, T., Ishikura, T., Makita, S., Uraushihara, K., Iiyama, R., Totsuka, T., Takeda, K., Akira, S., Watanabe, M., MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol 40 (2005), 16–23.
54. 54 Grabig, A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D.C., Erckenbrecht, J., Raupach, B., Sonnenborn, U., Eckert, J., Schumann, R.R., Wiedenmann, B., Dignass, A.U., Sturm, A., Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun 74 (2006), 4075–4082.
55. 55 Sahay, B., Patsey, R.L., Eggers, C.H., Salazar, J.C., Radolf, J.D., Sellati, T.J., CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance. PLoS Pathog, 5, 2009, e1000687.
56. 56 Leppkes, M., Roulis, M., Neurath, M.F., Kollias, G., Becker, C., Pleiotropic functions of TNF-alpha in the regulation of the intestinal epithelial response to inflammation. Int Immunol 26 (2014), 509–515.
57. 57 Beaurepaire, C., Smyth, D., McKay, D.M., Interferon-gamma regulation of intestinal epithelial permeability. J Interferon Cytokine Res 29 (2009), 133–144.
58. 58 Xiao, Y.T., Yan, W.H., Cao, Y., Yan, J.K., Cai, W., Neutralization of IL-6 and TNF-alpha ameliorates intestinal permeability in DSS-induced colitis. Cytokine 83 (2016), 189–192.
59. 59 Cario, E., Jung, S., Harder D'Heureuse, J., Schulte, C., Sturm, A., Wiedenmann, B., Goebell, H., Dignass, A.U., Effects of exogenous zinc supplementation on intestinal epithelial repair in vitro. Eur J Clin Invest 30 (2000), 419–428.
60. 60 Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M., Kalis, C., Keck, S., Galanos, C., Freudenberg, M., Beutler, B., CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6 (2005), 565–570.